CGEM - Cullinan Therapeutics, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
10/30/25 17:13	10/28/25	CGEM	Health	BioPrd	Biological Products, (No Diag	Lynx1 Capital Management LP	PR	T		P	1,392	8.40	166	2	8,964	I
10/21/25 19:00	10/14/25	CGEM	Health	BioPrd	Biological Products, (No Diag	Lynx1 Capital Management LP	PR	T		P.m	2,104	8.46	249	1	17,362	I
10/10/25 18:58	10/8/25	CGEM	Health	BioPrd	Biological Products, (No Diag	Lynx1 Capital Management LP	PR	T		P.m	9,827	6.73	1,460	10	16,195	I
6/7/22 16:33	6/6/22	CGEM	Health	BioPrd	Biological Products, (No Diag	Ahmed Nadim	MA	DO	P,CEO	P	100	12.40	8	New	8	D
6/3/22 18:24	6/1/22	CGEM	Financ	InvAdv	Investment Advice	Bvf Partners L P/il	CA	T		P	8,265	11.00	751		364	D
5/16/22 19:34	5/12/22	CGEM	Financ	InvAdv	Investment Advice	Bvf Partners L P/il	CA	T		P.m	10,064	9.07	1,110		319	D
4/5/22 18:45	4/1/22	CGEM	Financ	InvAdv	Investment Advice	Bvf Partners L P/il	CA	T		P	2,967	10.75	276	12	2,498	D
1/14/21 17:54	1/12/21	CGEM	Health	BioPrd	Biological Products, (No Diag	Ubs Oncology Impact Fund L.P.	E9	T		P.d	6,300	21.00	300	4	7,914	D
1/14/21 17:51	1/12/21	CGEM	Health	BioPrd	Biological Products, (No Diag	Gadicke Ansbert	MA	DT		P.d	6,300	21.00	300	4	8,195	M
1/14/21 17:30	1/12/21	CGEM	Health	BioPrd	Biological Products, (No Diag	Jovan-Embiricos Morana	MA	DT		P.d	4,200	21.00	200	999%	217	I
1/14/21 17:30	1/12/21	CGEM	Health	BioPrd	Biological Products, (No Diag	Hughes Owen	MA	DO	P,CEO	P	53	21.00	3	0	506	D
1/14/21 17:30	1/12/21	CGEM	Health	BioPrd	Biological Products, (No Diag	Trigilio Jeffrey	MA	O	CFO	P	47	21.00	2	New	2	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person